Navigation Links
Boston Scientific Announces Results For Second Quarter Ended June 30, 2013
Date:7/25/2013

-GAAP financial measures, is included in the exhibits attached to this news release.

CONTACT:

Denise Kaigler508-650-8330 (office)Corporate Affairs & CommunicationsBoston Scientific Corporationmedia@bsci.com Peter Lucht508-650-8796 (office)Global Media RelationsBoston Scientific Corporationmedia@bsci.com Michael Campbell508-650-8023 (office)Investor RelationsBoston Scientific Corporationinvestor_relations@bsci.com

  

 

BOSTON SCIENTIFIC CORPORATIONCONDENSED CONSOLIDATED GAAP RESULTS OF OPERATIONS

(Unaudited)

 Three Months EndedSix Months EndedJune 30,June 30,in millions, except per share data2013201220132012Net sales

$

1,809$

1,828$

3,570$

3,694Cost of products sold

5305781,1081,209Gross profit

1,2791,2502,4622,485Operating expenses:Selling, general and administrative expenses

6616481,2921,306Research and development expenses

223213427428Royalty expense

47488796Amortization expense

10199204195Goodwill impairment charge

—3,6024233,602Intangible asset impairment charges

5312953129Contingent consideration expense (benefit)

(18)1(41)11Restructuring charges

26283639Gain on divestiture

(34)—(40)—Litigation-related charges

—69130691,0594,8372,5715,875Operating income (loss)

220(3,587)(109)(3,390)Other income (expense):Interest expense

(65)(64)(130)(132)Other, net

(3)33(3)27Income (loss) before income taxes

152(3,618)(242)(3,495)Income tax expense (benefit)

22(40)(18)(30)Net income (loss)$130$(3,578)$(224)$(3,465)Net income (loss) per common share - basic$0.10$(2.51)$(0.17)$(2.42)Net income (loss) per common share - assuming dilution$0.10$(2.51)$(
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. American Laboratory Trading Continues Steady Growth with Expansion in Boston
2. Affordable Scrum Training in Boston,MA by Conscires Agile Practices
3. Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston
4. The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA
5. Verified Clinical Trials (VCT) Will Co-Present With SAFE-BioPharma At Bio-IT World April 10th In Boston, MA Exploring Identity Management In eClinical Trials
6. Boston Heart Diagnostics Awarded $450,000 in Tax Incentives from the Massachusetts Life Sciences Center
7. Local Leaders Convene in Boston to Share Industry Best Practices in Second “Business of Big Data” Summit
8. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.
9. Boston College researchers unique nanostructure produces novel plasmonic halos
10. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2012 Financial Results on January 29th
11. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... Winston-Salem, NC (PRWEB) March 30, 2015 ... Associates are pleased to announce the formation of ... clinical research centers specializing in the conduct of ... populations. VaxCorps clinical sites have successfully conducted ... extensive experience in seasonal and pandemic influenza as ...
(Date:3/30/2015)... , March 30, 2015  Heidrick & Struggles (Nasdaq: ... leadership consulting and culture shaping worldwide, ... firm to lead its global Healthcare and Life Sciences practice. ... Life Sciences, Mitchell will lead a team of more than ... Europe and Asia serving ...
(Date:3/30/2015)... NEW BRUNSWICK, N.J. , March 30, 2015 /PRNewswire-USNewswire/ ... research and innovation projects in the state of ... to its next round of grant funding, announced ... existing New Jersey Health Foundation Research Grants program, an ... to $35,000 each to fund early stage research projects ...
(Date:3/30/2015)... CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), ... commercialization of innovative therapeutics addressing cancer and other unmet ... focus on China , announced today ... approved the Company,s application to conduct a Phase 2 ... patients for its proprietary drug candidate ENMD-2076.  ...
Breaking Biology Technology:PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2Heidrick & Struggles Strengthens Leadership of Healthcare - Life Sciences Practice 2New Jersey Health Foundation Announces An Additional $1 Million To Fund Innovation and Research Grants in New Jersey 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5
... PAREXEL International,Corporation (Nasdaq: PRXL ) announced today ... Conference in Boston, MA. Josef von,Rickenbach, Chairman and Chief ... at 3:50 p.m. EDT on Thursday, September 4, 2008., ... available under the,"Upcoming Events" section on PAREXEL,s "Investors" homepage ...
... LLC, a New Jersey-based,leading provider of prescription co-pay ... has significantly expanded the scope of,the lawsuit that ... of the State,of New York, County of New ... subsidiary of McKesson Corporation. PSKW is,now seeking, in ...
... NATICK, Mass. and MUNICH, Germany, Sept. 1 ... today announced one-year data,from its landmark SYNTAX ... TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent,System to contemporary ... results demonstrated no statistically significant differences,between PCI ...
Cached Biology Technology:PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference 2PSKW Expands Its Lawsuit Against McKesson to Seek Assignment of McKesson's Patent Application 2Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 2Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 3Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 4Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 5
(Date:3/23/2015)... , March 23, 2015 SoundView Technology Group issues ... (NASDAQ: NXTD ) Wocket smart wallet. SoundView was one of ... on their experience with the Wocket in multiple scenarios and ... Whole Foods and other retailers, making both debit and credit ... also says, "If the company meets their plans in ...
(Date:3/20/2015)... and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced the ... Report" report to their offering. This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period ...
(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... possible cause of irritable bowel syndrome has been traced to ... the colon membrane, leading to hostile conditions that can produce ... that this RNA segment sends signals that stop the activity ... research has linked a shortage of glutamine in the gut ...
... generations of mountaineers since their ill-fated attempt to climb ... of scientists believe they have discovered another important part ... Andrew Irvine never returned from their pioneering expedition. The ... mystery and uses newly uncovered historical data collected during ...
... institutions led by the Georgia Institute of Technology has ... Science Foundation and the National Aeronautics and Space Administration ... understanding of how life started on Earth. Researchers will ... the spontaneous formation of functional polymers -- such as ...
Cached Biology News:Scientists target possible cause of 1 form of bowel disease 2Scientists target possible cause of 1 form of bowel disease 3Mallory and Irvine: Did extreme weather cause their disappearance? 2Georgia Tech awarded a $20M Center for Chemical Innovation from NSF and NASA 2Georgia Tech awarded a $20M Center for Chemical Innovation from NSF and NASA 3
... reagent is formulated specifically for Alkaline Phosphatase ... levels of activity for both the enzyme ... final dilution. This product has been ... the customer a longer shelf life, resistance ...
... Protein DetectorTM Microarray Dot Blot Kits overcome ... and quantitation over a wide range in ... ) detection. They are ideal for ... hundreds of samples for the presence of ...
AC input: 50-60 Hz 115-120 V...
... StabilZyme AP Conjugate Stabilizer is an ... bovine protein and other non-toxic stabilizing ... acid), pH 5.5 6.5. ... 0.02% methylisothiazolone and 0.02% bromonitrodioxane as ...
Biology Products: